Okay.
Ms. Elmslie, I will note that I might have to put forward motions to compel information from your committee that you said you would provide but have not been provided yet. I find that unacceptable.
Dr. Berthiaume, have you had any interaction with Pfizer or Health Canada with regard to the decision on the dosing interval going from three weeks to four months? Have they advised you in any way on that?